{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:57:54Z","timestamp":1772906274633,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Antimicrobial resistance, a major threat to human health, is mainly driven by the overuse of antimicrobials. The purpose of this study was to further investigate the relationship between antimicrobial use and resistance with a 15-year record in Southwest hospital, one of the largest hospitals in Southwest China and a university affiliated hospital, thus to further predict the antimicrobial resistance in an autoregressive integrated moving average (ARIMA) manner. Kirby-Bauer tests were carried out to figure out the drug sensitivity of Gram-negative bacterial. Antimicrobials (\u03b2-lactamase inhibitor complex, aminoglycosides, quinolones, third and fourth-generation cephalosporins, carbapenems, cephamycins, oxacephems, and sulfonamides) consumption were calculated according to World Health Organization (WHO) anatomical therapeutic chemical classification index and expressed as annual defined daily dose (DDD) or DDD per 1000 out patients. Resistance rates of levofloxacin-resistant <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>, ceftazidime-resistant <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>, amikacin-resistant <jats:italic toggle=\"yes\">Bacterium levans<\/jats:italic>, imipenem-resistant <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic> is positively correlated with the usage of aminoglycosides and quinolones; resistance rates of imipenem-resistant <jats:italic toggle=\"yes\">Acinetobacter baumanii<\/jats:italic> is positively correlated with the usage of carbapenemes (<jats:italic toggle=\"yes\">P<\/jats:italic>-value between the drug resistance of levofloxacin-resistant <jats:italic toggle=\"yes\">E. coli<\/jats:italic>, ceftazidime-resistant <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic> and the usage of aminoglycosides is under .05, the other <jats:italic toggle=\"yes\">P<\/jats:italic>-value are under .01); resistance rates of the drug resistance of levofloxacin-resistant <jats:italic toggle=\"yes\">E. coli<\/jats:italic> is positively correlated with the usage of oxacephems (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01); resistance rates of imipenem-resistant <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic> is positively correlated with the usage of oxacephems and sulfonamides (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01).<\/jats:p>\n            <jats:p>The present study presents one of the largest and longest retrospective analyses in China between antimicrobial consumption and antimicrobial resistance. Change of the usage of several antibacterial drugs has great influence on the drug resistance of Gram-negative bacterial. Of particular, ARIMA forecasting revealed that carbapenem related bacterial resistance should be closely watched.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017157","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:00:56Z","timestamp":1568340056000},"page":"e17157","source":"Crossref","is-referenced-by-count":17,"title":["Antimicrobial resistance surveillance and prediction of Gram-negative bacteria based on antimicrobial consumption in a hospital setting"],"prefix":"10.1097","volume":"98","author":[{"given":"Wei","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrmicro.2017.103","article-title":"Diagnosing antimicrobial resistance","volume":"15","author":"Burnham","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12879-017-2440-7","article-title":"Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit","volume":"17","author":"Axente","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"e0143995","DOI":"10.1371\/journal.pone.0143995","article-title":"Antimicrobial resistance in Escherichia coli recovered from feedlot cattle and associations with antimicrobial use","volume":"10","author":"Benedict","year":"2015","journal-title":"PLoS One"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12879-016-2051-8","article-title":"Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center","volume":"16","author":"Ma","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/605924","article-title":"Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial","volume":"30","author":"Camins","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R6-20230914","first-page":"912","article-title":"Impact of statewide program to promote appropriate antimicrobial drug use","volume":"11","author":"Belongia","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"(suppl_1)","key":"R7-20230914","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/cid\/ciw829","article-title":"Gram-negative bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group","volume":"64","author":"Doi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMra0904124","article-title":"Hospital-acquired infections due to gram-negative bacteria","volume":"362","author":"Peleg","year":"2010","journal-title":"N Engl J Med"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10\u200a\u00d7\u200a\u201920 Progress\u2014development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10096-014-2293-6","article-title":"Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009\u22122013)","volume":"34","author":"Zou","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"15901","DOI":"10.1038\/s41598-018-33165-9","article-title":"Temporal trends analysis of human brucellosis incidence in mainland China from 2004 to 2018","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jac\/dkr167","article-title":"Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India","volume":"66","author":"Goel","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jcpt.12432","article-title":"Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study","volume":"41","author":"Mladenovic-Antic","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"6318","key":"R16-20230914","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf4268","article-title":"Mechanisms of bacterial persistence during stress and antibiotic exposure","volume":"354","author":"Harms","year":"2016","journal-title":"Science"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/1574-6976.12077","article-title":"SOS, the formidable strategy of bacteria against aggressions","volume":"38","author":"Baharoglu","year":"2014","journal-title":"FEMS Microbiol Rev"},{"key":"R18-20230914","first-page":"DC08","article-title":"Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae isolates","volume":"9","author":"Joseph","year":"2015","journal-title":"J Clin Diagn Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:19:07Z","timestamp":1694726347000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017157"}},"subtitle":["A 15-year retrospective study"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":16,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017157","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}